Global Interventional Cardiology Market Report (2024 Update)

Interventional Cardiology

Vamstar Industry Report

The Global Market for Interventional Cardiology Devices – 2024

Vamstar’s latest analysis of interventional cardiology (IC) devices has identified a global market exceeding US$23 billion in 2023, more than an 8.3% increase over the previous year.

With sustained growth expected in mature markets and acceleration of usage in emerging economies, we forecast compound annual growth at 4.6% through 2028—at which time the market could reach US$30 billion.

The continued development of innovative medical devices, imaging modalities, and procedure techniques is leading to safer, more precise, minimally invasive procedures that support the treatment of a growing population suffering from cardiovascular diseases.

This latest report update features an extensive study of the current market landscape, presenting an in-depth analysis of devices, along with detailed forecasting of market opportunities segmented across geographies. Revenue, unit shipments, and average sales prices are included for each product type and geography.

Strategic Decision Support

Medical professionals, commercial teams, investors, and other stakeholders are provided actionable insights and comprehensive market intelligence for informed decision-making.

Commercial Guidance

Investors and commercial teams will find data-driven insights into growth prospects, technological trends, and market dynamics, aiding in the identification of investment opportunities and potential areas for expansion.

Competitive Edge

Device manufacturers and other suppliers are enabled with a detailed understanding of the competitive landscape, helping them to strategise effectively and stay ahead in the market.

Policy and Procurement Planning

Assists policy experts, procurement specialists, and hospital executives in understanding current trends and future directions of the IC market, facilitating better planning and procurement strategies

Educational Value

The report serves as a valuable educational resource for researchers, clinicians, and medical professionals seeking to deepen their knowledge of interventional cardiology market landscape.

Core Advantages of the Report

Download Preview

Download

Product Coverage

Aspiration Catheter
Atherectomy Device
Balloon Dilatation Catheter
- Coronary
- Peripheral
Bare Metal Stent
- Coronary
- Peripheral
Diagnostic Catheter
Drug-Eluting Stent
Guide Catheter (Sheath)
- Coronary
- Peripheral
Guidewire
- Coronary
- Peripheral
Heart Valve (TAVR, TMVR)
Intravascular Imaging and FFR
Introducer (Femoral and Radial)
Microcatheter
- Coronary
- Peripheral
Peripheral Coil System
- Detachable 18
- Detachable 35
- Pushable 18
- Pushable 35
Radial Compression Device
Vascular Closure Device

Geographic Coverage

North America
- Canada
- United States
South America
- Argentina
- Brazil
- Mexico
- Rest of South America
Europe
- France
- Germany
- Italy
- Spain
- United Kingdom
- Rest of Europe
Middle East and Africa
- Israel
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
Asia Pacific
- Australia
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific

About Vamstar Reports

Vamstar delivers comprehensive analysis of the medtech and pharma industries, meticulously analyzing financial statements, analyst briefings, tender awards, procedure volumes and hospital spending in pivotal markets. Additionally, Vamstar conducts interviews with product managers and industry thought leaders to substantiate data on market size, share and growth trends.

Leveraging cutting-edge technologies such as generative AI, natural language processing, and machine learning, Vamstar integrates the most up-to-date volume and pricing data into its reports. We have the unique ability to transform large amounts of institutional sales data into targeted and actionable insights. This capability allows Vamstar to quickly identify market opportunities for any product, despite how specialised, and map the entire ecosystem of buyers and suppliers in a particular geography.

Over 50 Years of Specialised Experience

Cumulatively, our team of subject matter experts possesses over 50 years of specialised experience in tracking the dynamic landscape of healthcare delivery. This depth of expertise empowers us to understand and interpret the importance of emerging trends, forthcoming product launches, and pivotal technological advancements. By leveraging this experience, we assure our stakeholders that significant developments within the industry are incorporated into our studies.

Our analysis boasts three distinctive advantages. Firstly, our proprietary market tracker platform grants unparalleled insight into institutional sales, providing clients with a nuanced understanding of procurement trends. Secondly, we offer up-to-date data on net prices across key markets, ensuring informed decision-making amid market fluctuations. Lastly, our global manufacturer coverage offers comprehensive insights, allowing clients to navigate regulatory changes and competitive landscapes confidently.